CLINICAL_TRIALS
trial_result
· 2021-01-07
Clinical Trial Update: Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML) [Phase 2]
Summary
Phase 2 trial evaluating azacitidine after allogeneic stem cell transplantation for chronic myeloid leukemia has been completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Stem Cell Transplantation, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-07